Article
HGF and CXCL13, Two Antagonizing Cytokines in Lung Inflammation and Fibrosis, Predict the…
Research square · 2021 · Matthieu Perreau, author Madeleine Suffiotti, author Pedro Marques-Vidal, author Aurelie Wiedemann, author Yves Levy, author Cédric Laouénan, author Jade Ghosn, author Craig Fenwick, author Denis Comte, author Thierry Roger, author Jean Regina, author Peter Vollenweider, author Gerard Waeber, author Mauro Oddo, author Thierry Calandra, author Giuseppe Pantaleo, author
Key facts
| Title | HGF and CXCL13, Two Antagonizing Cytokines in Lung Inflammation and Fibrosis, Predict the Severity and the Mortalityof COVID-19: Immunological Predictors of severe COVID-19 |
|---|---|
| First author | Matthieu Perreau, author Madeleine Suffiotti, author Pedro Marques-Vidal, author Aurelie Wiedemann, author Yves Levy, author Cédric Laouénan, author Jade Ghosn, author Craig Fenwick, author Denis Comte, author Thierry Roger, author Jean Regina, author Peter Vollenweider, author Gerard Waeber, author Mauro Oddo, author Thierry Calandra, author Giuseppe Pantaleo, author |
| Journal | Research square |
| Published | Apr 10, 2021 |
| DOI | 10.21203/rs.3.rs-241266/v1 |
| Product codes mentioned | MVU |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1